A new classification plot for the C-peptide suppression test

Journal of the Pancreas

Volumn 3, Issue 1, 2002, Pages 16-25

  Saddig, Christiane ^a   Bender, Ralf ^b   Starke, Archim A R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

Author keywords

C peptide (diagnostic use; Hypoglycemia (diagnosis); Insulinoma (diagnosis; Laboratory techniques and procedures; Secretion)

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; NEUTRAL INSULIN; DIAGNOSTIC AGENT; HYPERGLYCEMIC AGENT;

ADULT; ARTICLE; CLASSIFICATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIET RESTRICTION; DISCRIMINANT ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULINOMA; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PLOTS AND CURVES; PROBABILITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; ADOLESCENT; AGED; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; PANCREAS ISLET CELL TUMOR; PANCREAS TUMOR; SECRETION;

ADENOMA, ISLET CELL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; C-PEPTIDE; FEMALE; HUMANS; HYPOGLYCEMIA; INSULIN; INSULIN ANTAGONISTS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS;

EID: 0036359174     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Service FJ. Clinical presentation and laboratory evaluation of hypoglycemic disorders in adults. In: Service FJ, ed. Hypoglycemic Disorders. Boston, MA, USA: GK Hall Medical Publishers, 1983: 73-95.
2. Service FJ. Hypoglycemic disorders. N Engl J Med 1995; 332:1144-52. [AN 95214682]
3. Fajans SS, Floyd JC Jr. Fasting hypoglycemia in adults. N Engl J Med 1976; 294:766-72. [AN 76149875]
4. Service FJ, Dale AJD, Elveback LR, Jiang NS. Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc 1976; 51:417-29. [AN 76218696]
5. Marks V. Progress report. Diagnosis of insulinoma. Gut 1971; 12:835-43. [AN 72050321]
6. Service FJ, O'Brien PC, Kao PC, Young WF Jr. C-peptide suppression test: effects of gender, age, and body mass index; implications for the diagnosis of insulinoma. J Clin Endocrinol Metab 1992; 74:204-10. [AN 92091435]
7. Service FJ, Horwitz DL, Rubenstein AH, Kuzuya H, Mako ME, Reynolds C, Molnar GD. C-peptide suppression test for insulinoma. J Lab Clin Med 1977; 90:180-6. [AN 77208713]
8. Scarlett JA, Mako ME, RubensteinAH, Blix PM, Goldman J, Horwitz DL, et al. Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies. N Engl J Med 1977; 297:1029-32. [AN 78010319]
9. Senator GB, Rainbow SJ, Greenwood RH, Mahler RF, Woodhead JS, Hales CN. Plasma C-peptide measurement in the diagnosis of pancreatic insulinoma with special reference to insulin-induced hypoglycaemia. In: Beyer J, Krause U, Naegele W, eds. C-peptide. Konstanz: Schnetztor-Verlag, 1977: 185-96.
10. Turner RC, Johnson PC. Suppression of insulin release by fish-insulin induced hypoglycemia: with reference to the diagnosis of insulinomas. Lancet 1973; 1:1483-5. [AN 73200566]
11. Turner RC, Harris E. Diagnosis of insulinomas by suppression tests. Lancet 1974; 2:188-90. [AN 74277792]
12. Turner RC, Heding LG. Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas. Diabetologia 1977; 13:571-7. [AN 78065128]
13. Horwitz DL, Rubenstein AH, Reynolds C, Molnar GD, Yanaihara N. Prolonged suppression of insulin release by insulin-induced hypoglycemia: demonstration by C-peptide assay. Horm Metab Res 1975; 7:449-52. [AN 76119483]
14. Service FJ, Nelson RL. Insulinoma. Compr Ther 1980; 6:70-4. [AN 80133398]
15. Nauck MA, Baum F, Seidensticker F, Roder M, Dinesen B, Creutzfeldt W. A hyperinsulinaemic, sequentially eu- and hypoglycemic clamp test to characterize autonomous insulin secretion in patients with insulinoma. Eur J Clin Invest 1997; 27:109-15. [AN 97214938]
16. Nauck M, Stöckmann F, Creutzfeldt W. Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients. Eur J Clin Invest 1990; 20:15-28. [AN 90201158]
17. Yki-Jarvinen H, Pelkonen R, Koivisto VA. Failure to suppress C-peptide secretion by euglycaemic hyperinsulinemia: a new diagnostic test for insulinoma? Clin Endocrinol (Oxf) 1985; 23:461-6. [AN 86054064]
18. Gin H, Brottier E, Dupuy B, Guillaume D, Ponzo J, Aubertin J. Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism. Arch Intern Med 1987; 147:985-7. [AN 87212283]
19. Reynolds JH, Kaminsky NI, Schade DS, Eaton RP. Use of a computerized glucose clamp technique to diagnose an insulinoma. Ann Intern Med 1984; 101:648-9. [AN 85020958]
20. Berger M, Bordi C, Cuppers HJ, Berchtold P, Gries FA, Muntefering H, et al. Functional and morphologic characterization of human insulinomas. Diabetes 1983; 32:921-31. [AN 84005536]
21. Curnow RT, Carey RM, Taylor A, Johanson A, Murad F. Somatostatin inhibition of insulin and gastrin secretion in pancreatic islet-cell carcinoma. N Engl J Med 1975; 292:1385-6. [AN 75175090]
22. Rayfield EJ, Pulini M, Golub A, Rubenstein AH, Horwitz DL. Nonautonomous function of a pancreatic insulinoma. J Clin Endocrinol Metab 1976; 43:1307-11. [AN 77071716]
23. Lorenzi M, Gerich JE, Karam JH, Forsham PH. Failure of somatostatin to inhibit tolbutamide-induced insulin secretion in patients with insulinomas: a possible diagnostic tool. J Clin Endocrinol Metab 1975; 40:1121-4. [AN 75170436]
24. Scuro LA, Lo Cascio V, Adami S, Galvanini G, Bianchi I, Cominacini L, Corgnati A. Somatostatin inhibition of insulin secretion in insulin-producing tumors. Metabolism 1976; 25:603-9. [AN 76195514]
25. SAS. SAS/STAT guide for personal computers, version 6. Cary, NC, USA: SAS Institute, 1987.
26. Service FJ, O'Brien PC, McMahon MM, Kao PC. C-peptide during the prolonged fast in insulinoma. J Clin Endocrinol Metab 1993; 76:655-9. [AN 93186997]
27. Ipp E, Sinai Y, Forster B, Cortez C, Baroz J, Nesher R, Cerasi E. A glucose reduction challenge in the differential diagnosis of fasting hypoglycemia: a two center study. J Clin Endocrinol Metab 1990; 70:711-7. [AN 90171188]
28. Starke AA, Frilling A, Becker H, Roher HD, Berger M. Are CAT-scans necessary for preoperative localization of insulinomas? Eur J Med 1992; 1:411-3. [AN 94080366]
29. Schumacher B, Lubke HJ, Frieling T, Strohmeyer G, Starke AA. Prospective study on the detection of insulinomas by endoscopic ultrasonography. Endoscopy 1996; 28:273-6. [AN 96375478]
30. Rosch T, Lightdale CJ, Botet JF, Boyce GA, Sivak MV Jr, Yasuda K, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992; 326:1721-6. [AN 92278388]
31. Krudy AG, Doppmann JL, Jensen RT, Norton JA, Collen MJ, Shawker TH, et al. Localization of islet cell tumors by dynamic CT: comparison with plain CT, arteriography, sonography, and venous sampling. AJR Am J Roentgenol 1984; 143:585-9. [AN 84277321]